GB1231412A - - Google Patents
Info
- Publication number
- GB1231412A GB1231412A GB1231412DA GB1231412A GB 1231412 A GB1231412 A GB 1231412A GB 1231412D A GB1231412D A GB 1231412DA GB 1231412 A GB1231412 A GB 1231412A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dehydro
- chloro
- methyl
- fluoro
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
1,231,412. Contraceptive compositions. SCHERING A.G. 19 April, 1968 [19 April, 1967], No. 18661/68. Heading A5B. A contraceptive composition in unit dosage form for injection or implantation and which is free from oestrogens comprises a carrier and a gestagen (progestational hormone) other than progesterone, the gestagen being present in an amount having an activity, as measured by its action on the cervical mucus, corresponding to that produced by from 1 to 20 mg of 19-nor-17α-hydroxy progesterone caproate when administered in the same way. In addition to this compound, suitable gestagens are progesterone-3-enol-esters and the esters of 6α- methyl-; 6-methyl-6-dehydro; 6-chloro (or fluoro)-6-dehydro; 6-chloro (or fluoro)-6-debydro-16α (or #)-methyl-; 6 16-dimethyl-6-dehydro-; 6-methyl (or chloro)-6-dehydro-16- methylene and 1,2-methylene-6-chloro (or fluoro)-6-dehydro-17α-hydroxy progesterones and 17α-ethynyl-18-homo-19-nor testorterone and its esters. Other less suitable hormones are also mentioned. Typical compositions are oily solutions for injection which may comprise a solubility promoter, e.g. benzyl benzoate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESC040583 | 1967-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1231412A true GB1231412A (en) | 1971-05-12 |
Family
ID=7435756
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0714/71A Expired GB1253500A (en) | 1967-04-19 | 1968-04-19 | Method of contraception |
GB1231412D Expired GB1231412A (en) | 1967-04-19 | 1968-04-19 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0714/71A Expired GB1253500A (en) | 1967-04-19 | 1968-04-19 | Method of contraception |
Country Status (6)
Country | Link |
---|---|
US (1) | US3758687A (en) |
BE (1) | BE713958A (en) |
DE (1) | DE1617839A1 (en) |
FR (1) | FR8061M (en) |
GB (2) | GB1253500A (en) |
NL (1) | NL6805612A (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4171358A (en) * | 1974-04-19 | 1979-10-16 | Eli Lilly And Company | Novel contraceptive method |
US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5433219A (en) * | 1992-09-23 | 1995-07-18 | Spery; Nanette S. | Receptive condom assembly |
AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
US9844558B1 (en) | 2015-04-30 | 2017-12-19 | Amag Pharmaceuticals, Inc. | Methods of reducing risk of preterm birth |
US10556922B2 (en) | 2015-09-29 | 2020-02-11 | Amag Pharmaceuticals, Inc. | Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate |
-
1967
- 1967-04-19 DE DE19671617839 patent/DE1617839A1/en active Pending
-
1968
- 1968-04-19 NL NL6805612A patent/NL6805612A/xx unknown
- 1968-04-19 BE BE713958D patent/BE713958A/xx unknown
- 1968-04-19 GB GB0714/71A patent/GB1253500A/en not_active Expired
- 1968-04-19 GB GB1231412D patent/GB1231412A/en not_active Expired
- 1968-04-19 FR FR148725A patent/FR8061M/fr not_active Expired
-
1971
- 1971-04-20 US US00135814A patent/US3758687A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB1253500A (en) | 1971-11-17 |
FR8061M (en) | 1970-07-06 |
US3758687A (en) | 1973-09-11 |
BE713958A (en) | 1968-10-21 |
NL6805612A (en) | 1968-10-21 |
DE1617839A1 (en) | 1971-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hulka et al. | Effect of synthetic progestational agents on allograft rejection and circulating antibody production | |
SE7416039L (en) | ||
US4066757A (en) | Oral contraceptive regimen | |
US3755573A (en) | Fertility control empoying quinestrol and quingestanol acetate | |
US3755575A (en) | Pharmaceutical compositions | |
Saunders et al. | Progesterone-like activity of a series of 19-nortestosterones | |
GB1231412A (en) | ||
Paulsen | Progestin metabolism: special reference to estrogenic pathways | |
Overbeek et al. | Nor-androstenolonephenylpropionate, a new potent anabolic ester | |
Kind et al. | Anti-ovulatory activity of subcutaneously injected steroids in the adult oestrus rabbit | |
Seegar Jones et al. | The physiological significance of the estrogen: progesterone ratio on vaginal cornification in the rat | |
Zanartu | Long-term contraceptive effect of injectable progestogens: inhibition and reestabilishment of fertility | |
GB1462893A (en) | Method for fertile breeding control in female bovine | |
Jadrijevic et al. | Antifibromatogenic Activity of 19-Nor-a-ethinyltestosterone in the Guinea Pig. | |
Naqvi et al. | Interceptives: Drugs interrupting pregnancy after implantation | |
GB1287602A (en) | 4,6-DICHLORO-Delta<4.6>-OESTRADIENES | |
Saunders | A singularly long-acting ether of testosterone | |
GB1270614A (en) | Stable aqueous steroid phosphate solutions | |
GB1488995A (en) | Compositions containing anti-androgenic compounds | |
Greenblatt et al. | Pituitary-ovarian relationships | |
GB1214712A (en) | Contraceptive preparations | |
IE34308B1 (en) | 11beta,13beta dialkylgona-1,3,5(10)-trien-3-ol 3-cycloalkyl ethers | |
Swyer | Progestogens and their clinical uses: Part I | |
Greenwald | Anti-ovulatory potency of various steroids, determined by single injection into female hamsters | |
GB1311680A (en) | Contraceptive preparations and method of contraception |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |